Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	October 2025 Share Repurchase Program	October 2025 Share Repurchase Program - Put Option	Common stock	Common stock October 2025 Share Repurchase Program	Common stock October 2025 Share Repurchase Program - Put Option	Additional paid-in capital	Additional paid-in capital October 2025 Share Repurchase Program	Additional paid-in capital October 2025 Share Repurchase Program - Put Option	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024				112,550,156
Beginning balance at Dec. 31, 2024	$ 455,656			$ 113			$ 1,193,022			$ 2,676	$ (740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,255						32,255
Common stock issued under employee stock plans (in shares)				1,808,876
Common stock issued under employee stock plans	7,163			$ 2			7,161
Taxes related to net share settlement of equity awards	(26,447)						(26,447)
Repurchase of common stock (in shares)				(1,476,456)
Repurchase of common stock	(61,264)			$ (2)			(61,262)
Unrealized (loss) income on derivative instruments, net of tax	(6,231)									(6,231)
Unrealized income (loss) on available for sale securities, net of tax	2,393									2,393
Common stock issued for debt conversion (in shares)				32
Common stock issued for debt conversion	1						1
Net loss	(35,783)										(35,783)
Ending balance (in shares) at Mar. 31, 2025				112,882,608
Ending balance at Mar. 31, 2025	367,743			$ 113			1,144,730			(1,162)	(775,938)
Beginning balance (in shares) at Dec. 31, 2024				112,550,156
Beginning balance at Dec. 31, 2024	455,656			$ 113			1,193,022			2,676	(740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) income on derivative instruments, net of tax	12,553
Unrealized income (loss) on available for sale securities, net of tax	3,153
Net loss	(101,549)
Ending balance (in shares) at Sep. 30, 2025				117,897,308
Ending balance at Sep. 30, 2025	604,835			$ 118			1,428,039			18,382	(841,704)
Beginning balance (in shares) at Mar. 31, 2025				112,882,608
Beginning balance at Mar. 31, 2025	367,743			$ 113			1,144,730			(1,162)	(775,938)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	33,859						33,859
Common stock issued under employee stock plans (in shares)				163,501
Common stock issued under employee stock plans	0
Taxes related to net share settlement of equity awards	(1,352)						(1,352)
Repurchase of common stock (in shares)				(1,003,885)
Repurchase of common stock	(38,736)			$ (1)			(38,735)
Unrealized (loss) income on derivative instruments, net of tax	15,736									15,736
Unrealized income (loss) on available for sale securities, net of tax	(77)									(77)
Common stock issued for debt conversion (in shares)				4,885
Common stock issued for debt conversion	150						150
Net loss	(35,824)										(35,824)
Ending balance (in shares) at Jun. 30, 2025				112,047,109
Ending balance at Jun. 30, 2025	341,499			$ 112			1,138,652			14,497	(811,762)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	31,550						31,550
Common stock issued under employee stock plans (in shares)				273,665
Common stock issued under employee stock plans	7,186						7,186
Taxes related to net share settlement of equity awards	(631)						(631)
Unrealized (loss) income on derivative instruments, net of tax	3,048									3,048
Unrealized income (loss) on available for sale securities, net of tax	837									837
Common stock issued for debt conversion (in shares)				8,180,968
Common stock issued for debt conversion	251,288			$ 8			251,280
Settlement of capped call transactions (in shares)				(2,604,434)
Settlement of capped call transactions	0			$ (2)			2
Net loss	(29,942)										(29,942)
Ending balance (in shares) at Sep. 30, 2025				117,897,308
Ending balance at Sep. 30, 2025	604,835			$ 118			1,428,039			18,382	(841,704)
Beginning balance (in shares) at Dec. 31, 2025				117,546,852
Beginning balance at Dec. 31, 2025	598,656			$ 118			1,444,885			23,132	(869,479)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	33,739						33,739
Common stock issued under employee stock plans (in shares)				2,622,743
Common stock issued under employee stock plans	7,970			$ 2			7,968
Taxes related to net share settlement of equity awards	(17,386)						(17,386)
Repurchase of common stock (in shares)					(4,429,520)	(925,925)
Repurchase of common stock		$ (110,000)	$ (20,009)		$ (4)	$ (1)		$ (109,996)	$ (20,008)
Unrealized (loss) income on derivative instruments, net of tax	(952)									(952)
Unrealized income (loss) on available for sale securities, net of tax	(1,651)									(1,651)
Net loss	(36,854)										(36,854)
Ending balance (in shares) at Mar. 31, 2026				114,814,150
Ending balance at Mar. 31, 2026	453,513			$ 115			1,339,202			20,529	(906,333)
Beginning balance (in shares) at Dec. 31, 2025				117,546,852
Beginning balance at Dec. 31, 2025	598,656			$ 118			1,444,885			23,132	(869,479)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) income on derivative instruments, net of tax	(4,456)
Unrealized income (loss) on available for sale securities, net of tax	(5,638)
Net loss	(125,311)
Ending balance (in shares) at Sep. 30, 2026				115,298,568
Ending balance at Sep. 30, 2026	433,907			$ 115			1,415,544			13,038	(994,790)
Beginning balance (in shares) at Mar. 31, 2026				114,814,150
Beginning balance at Mar. 31, 2026	453,513			$ 115			1,339,202			20,529	(906,333)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	34,619						34,619
Common stock issued under employee stock plans (in shares)				39,725
Common stock issued under employee stock plans	0
Taxes related to net share settlement of equity awards	(3,460)						(3,460)
Unrealized (loss) income on derivative instruments, net of tax	7,536									7,536
Unrealized income (loss) on available for sale securities, net of tax	(906)									(906)
Net loss	(46,809)										(46,809)
Ending balance (in shares) at Jun. 30, 2026				114,853,875
Ending balance at Jun. 30, 2026	444,493			$ 115			1,370,361			27,159	(953,142)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	41,157						41,157
Common stock issued under employee stock plans (in shares)				444,693
Common stock issued under employee stock plans	6,027						6,027
Taxes related to net share settlement of equity awards	(2,001)						(2,001)
Unrealized (loss) income on derivative instruments, net of tax	(11,040)									(11,040)
Unrealized income (loss) on available for sale securities, net of tax	(3,081)									(3,081)
Net loss	(41,648)										(41,648)
Ending balance (in shares) at Sep. 30, 2026				115,298,568
Ending balance at Sep. 30, 2026	$ 433,907			$ 115			$ 1,415,544			$ 13,038	$ (994,790)